Papers

14

Total Citations

90

H-Index

5

About

Dr. Yuki Hirata is a pioneering surgical oncologist whose research focuses on the transformative role of robotic surgery in gastrointestinal oncology, particularly for gastric, pancreatic, and esophageal cancers. Her major contributions center on demonstrating the safety, oncological quality, and opioid-sparing benefits of minimally invasive robotic approaches. Through landmark studies, Dr. Hirata has shown that robotic gastrectomy and pancreatoduodenectomy can significantly reduce inpatient opioid use compared to open surgery, addressing the critical opioid crisis while maintaining surgical outcomes. Her work analyzing nationwide trends using the National Cancer Database has documented improving short-term safety and oncological metrics for robotic gastrectomy in the United States. With over 80 cumulative citations across her most impactful papers, including studies on cost analysis of robotic hepatectomy and technical refinements for gastroesophageal junction cancer, Dr. Hirata has established herself as a leading voice in evidence-based robotic surgery. Her ASO Author Reflections provide valuable perspective on the evolution of surgical techniques, making her research essential reading for surgeons and trainees navigating the integration of robotics into modern oncologic practice.

Research Focus

Key Achievements

5
H-Index
14
Papers
90
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Short-Term and Textbook Surgical Outcomes During the Implementation of a Robotic Gastrectomy Program
16 citations · 2023
📈 Most Prolific Year: 2022 (5 Papers)
🤝 Key Collaborators: 46
🏛 Institutions: The University of Texas MD Anderson Cancer Center, Keio University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago